HRTX - ヘロン・セラピュ―ティクス (Heron Therapeutics Inc. ) ヘロン・セラピュ―ティクス

 HRTXのチャート


 HRTXの企業情報

symbol HRTx
会社名 Heron Therapeutics Inc (ヘロン・セラピュ―ティクス)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 ヘロン・セラピューティクス(Heron Therapeutics Inc.)は癌と痛みに苦しむ患者のための医薬品の開発に従事するバイオテクノロジー企業。同社の薬品候補には、「SUSTOL」、「HTX-019」、「HTX-011」が含まれる。薬品候補のすべては、Biochronomer薬物送達技術を含む科学技術プラットフォームを利用する。中等度催吐性リスク化学療法(MEC)または高度催吐性化学療法(HEC)に関連する急性と遅延の化学療法誘発性悪心・嘔吐(CINV)の予防のために、同社はSUSTOL(グラニセトロン)徐放性注射剤を開発する。HTX-019は、ニューロキニン1(NK1)受容体アンタゴニストであるアプレピタントの静脈内製剤であり、CINVの予防のために開発される。HTX-011は、抗炎症性メロキシカムとの一定用量の組み合わせにおける局所麻酔薬ブピバカインの長期作用性製剤であり、術後疼痛の予防のために開発される。HTX-011は第2相臨床試験中である。   ヘロン・セラピュ―ティクスは米国の製薬会社。同社の独自技術のポリマ―ベ―スの薬物送達プラットフォ―ムBiochromerを使用して製品を開発する。主力製品のグラニセトロン注射「SUSTOL」は、急性遅延発症化学療法に伴う悪心・嘔吐の予防薬で、これは医薬品の活性成分の作用持続時間を延長することで効果を見込む。   Heron Therapeutics, Inc. is a biotechnology company, which engages in the development of pharmaceutical products for patients suffering from cancer. Its products portfolio include SUSTOL, Cinvanti, HTX-011, and HTX-034. The company was founded in February 1983 and is headquartered in Redwood City, CA.
本社所在地 4242 Campus Point Court Suite 200 San Diego CA 92121 USA
代表者氏名 Kevin C. Tang ケヴィン・C・タング
代表者役職名 Independent Chairman of the Board
電話番号 +1 650-366-2626
設立年月日 30348
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数 145人
url www.appharma.com
nasdaq_url https://www.nasdaq.com/symbol/hrtx
adr_tso
EBITDA EBITDA(百万ドル) -192.54600
終値(lastsale) 31
時価総額(marketcap) 2409762804
時価総額 時価総額(百万ドル) 2264.4
売上高 売上高(百万ドル) 47.46900
企業価値(EV) 企業価値(EV)(百万ドル) 1870.548
当期純利益 当期純利益(百万ドル) -195.29100
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Heron Therapeutics Inc revenues increased from $12.1M to $28.8M. Net loss decreased 2% to $90.9M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Stock-based Compensation in SGA decrease of 7% to $4.6M (expense) Stock-based Compensation in SGA decrease of 6% to $4.8M (expense).

 HRTXのテクニカル分析


 HRTXのニュース

   European advisory group backs Heron drug for post-op pain (NASDAQ:HRTX)  2020/07/24 13:23:33 Seeking Alpha
The European Medicines Agency's advisory group CHMP has adopted a positive opinion recommending approval of Heron Therapeutics' (NASDAQ:HRTX) Zynrelef (for
   Heron Therapeutics readies mid-stage study of aprepitant for COVID-19 (NASDAQ:HRTX)  2020/07/14 17:07:02 Seeking Alpha
Heron Therapeutics (HRTX +3.3%) perks up on average volume in apparent response to the posting in ClinicalTrials.gov of a Phase 2 clinical trial, GUARDS-1,
   Heron Therapeutics: What Now? - Bret Jensen  2020/06/30 14:32:38 Seeking Alpha
Yesterday, Heron Therapeutics (HRTX) unexpectedly got its second Complete Response Letter {CRL} from the FDA in response to its marketing application for HTX-011 to treat post-operative pain. This was a most unexpected response given the compound has both Fast Track and Breakthrough Therapy status for this indication and the industry is in desperate need of less addictive pain management options. This disappointment caused a steep sell off in the stock in trading Monday.
   Pacira BioSciences surges after Heron CRL (NASDAQ:PCRX)  2020/06/29 13:56:39 Seeking Alpha
Heron Therapeutics is having a tough day after receiving a Complete Response Letter from the FDA for HTX-011 for management of post-operative pain. That's
   FDA rejects Heron Therapeutics' NDA for HTX-011 for postoperative pain (NASDAQ:HRTX)  2020/06/29 13:10:44 Seeking Alpha
Heron Therapeutics (NASDAQ:HRTX) is down 11% premarkket in reaction to its announcement that it received a Complete Response Letter (CRL) from the FDA rega
   The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment  2020/03/11 12:03:52 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 10) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Aytu Bioscience Inc (NASDAQ: AYTU ) ( announced a deal to distribute COVID-19 test) Centogene NV (NASDAQ: CNTG ) Forty Seven Inc (NASDAQ: FTSV ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on March 10) Accelerate Diagnostics Inc (NASDAQ: AXDX ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) ADMA Biologics Inc (NASDAQ: ADMA ) Aeglea Bio Therapeutics Inc (NASDAQ: AGLE ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Affimed NV (NASDAQ: AFMD ) Akari Therapeutics PLC (NASDAQ: AKTX ) Akcea Therapeutics Inc (NASDAQ: AKCA ) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN ) Alkermes Plc (NASDAQ: ALKS ) Allena Pharmaceuticals Inc (NASDAQ: ALNA ) ANCHIANO THERAP/S ADR (NASDAQ: ANCN ) AngioDynamics, Inc. (NASDAQ: ANGO ) ANI Pharmaceuticals Inc (NASDAQ: ANIP ) Anixa Biosciences Inc (NASDAQ: ANIX ) AnPac Bio-Medical Science Co Ltd – ADR (NASDAQ: ANPC ) Aptevo Therapeutics Inc (NASDAQ: APVO ) Aptinyx Inc (NASDAQ: APTX ) Assertio Therapeutics Inc (NASDAQ: ASRT ) Atara Biotherapeutics Inc (NASDAQ: ATRA ) Atossa Therapeutics Inc (NASDAQ: ATOS ) Autolus Therapeutics Ltd – ADR (NASDAQ: AUTL ) AxoGen, Inc Common Stock (NASDAQ: AXGN ) Axovant Gene Therapies Ltd (NASDAQ: AXGT ) Bausch Health Companies Inc (NYSE: BHC ) Bellicum Pharmaceuticals Inc (NASDAQ: BLCM ) BENITEC BIOPHAR/S ADR (NASDAQ: BNTC ) BioLife Solutions Inc (NASDAQ: BLFS ) bluebird bio Inc (NASDAQ: BLUE ) Black Diamond Therapeutics Inc (NASDAQ: BDTX ) Capricor Therapeutics Inc (NASDAQ: CAPR ) Celcuity Inc (NASDAQ: CELC ) Cerecor Inc (NASDAQ: CERC ) Chembio Diagnostics Inc (NASDAQ: CEMI ) Eiger Biopharmaceuticals Inc (NASDAQ: EIGR ) Enochian Biosciences Inc (NASDAQ: ENOB ) Entasis Therapeutics Holdings Inc (NASDAQ: ETTX ) Eton Pharmaceuticals Inc (NASDAQ: ETON ) Evolus Inc (NASDAQ: EOLS ) Exicure Inc (NASDAQ: XCUR ) Eyepoint Pharmaceuticals Inc (NASDAQ: EYPT ) Five Prime Therapeutics Inc (NASDAQ: FPRX ) Gossamer Bio Inc (NASDAQ: GOSS ) Gritstone Oncology Inc (NASDAQ: GRTS ) GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH ) Heron Therapeutics Inc (NASDAQ: HRTX ) Incyte Corporation (NASDAQ: INCY ) INmune Bio Inc (NASDAQ: INMB ) Integra Lifesciences Holdings Corp (NASDAQ: IART ) Invivo Therapeutics Holdings Corp (NASDAQ: NVIV ) Jaguar Health Inc (NASDAQ: JAGX ) Jazz Pharmaceuticals PLC (NASDAQ: JAZZ ) Kura Oncology Inc (NASDAQ: KURA ) Lantheus Holdings Inc (NASDAQ: LNTH ) TapImmune Inc.
   The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap 600 Index  2020/03/10 13:19:55 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 9.) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Enzo Biochem, Inc. (NYSE: ENZ ) Centogene NV (NASDAQ: CNTG ) Inovio Pharmaceuticals Inc (NASDAQ: INO ) Spherix Inc (NASDAQ: SPEX ) ( added to Friday's advance on clinching an option agreement for coronavirus treatment) Down In The Dumps (Biotech stocks that hit 52-week lows March 9.) ABIOMED, Inc. (NASDAQ: ABMD ) Acasti Pharma Inc (NASDAQ: ACST ) Achieve Life Sciences Inc (NASDAQ: ACHV ) Acorda Therapeutics Inc (NASDAQ: ACOR ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) ADMA Biologics Inc (NASDAQ: ADMA ) Aeglea Bio Therapeutics Inc (NASDAQ: AGLE ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Affimed NV (NASDAQ: AFMD ) Akers Biosciences Inc (NASDAQ: AKER ) Akorn, Inc. (NASDAQ: AKRX ) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) Alexion Pharmaceuticals, Inc.
   Heron Therapeutics (HRTX) May Report Negative Earnings: Know the Trend Ahead of Q4 Release  2020/02/21 18:34:46 Zacks Investment Research
Heron Therapeutics (HRTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   Global Postoperative Pain: Market Forecast to 2028 - Featuring Heron Therapeutics, Pfizer, Cara Therapeutics & Neumentum Pharmaceuticals Among Others - ResearchAndMarkets.com  2020/02/12 15:10:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Postoperative Pain - Market Insights, Epidemiology and Market Forecast - 2028" report has been added to ResearchAndMarkets.com's offering. This report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of Postoperative Pain in the United States, EU5 (Germany, Spain, Italy, France and the United Kingdom), and Japan. The report provides the current treatment practices, emerging drugs, market share
   Introducing Heron Therapeutics (NASDAQ:HRTX), The Stock That Zoomed 186% In The Last Five Years  2020/01/27 16:01:21 Yahoo Finance
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But when you pick a…
   The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment  2020/03/11 12:03:52 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 10) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Aytu Bioscience Inc (NASDAQ: AYTU ) ( announced a deal to distribute COVID-19 test) Centogene NV (NASDAQ: CNTG ) Forty Seven Inc (NASDAQ: FTSV ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on March 10) Accelerate Diagnostics Inc (NASDAQ: AXDX ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) ADMA Biologics Inc (NASDAQ: ADMA ) Aeglea Bio Therapeutics Inc (NASDAQ: AGLE ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Affimed NV (NASDAQ: AFMD ) Akari Therapeutics PLC (NASDAQ: AKTX ) Akcea Therapeutics Inc (NASDAQ: AKCA ) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN ) Alkermes Plc (NASDAQ: ALKS ) Allena Pharmaceuticals Inc (NASDAQ: ALNA ) ANCHIANO THERAP/S ADR (NASDAQ: ANCN ) AngioDynamics, Inc. (NASDAQ: ANGO ) ANI Pharmaceuticals Inc (NASDAQ: ANIP ) Anixa Biosciences Inc (NASDAQ: ANIX ) AnPac Bio-Medical Science Co Ltd – ADR (NASDAQ: ANPC ) Aptevo Therapeutics Inc (NASDAQ: APVO ) Aptinyx Inc (NASDAQ: APTX ) Assertio Therapeutics Inc (NASDAQ: ASRT ) Atara Biotherapeutics Inc (NASDAQ: ATRA ) Atossa Therapeutics Inc (NASDAQ: ATOS ) Autolus Therapeutics Ltd – ADR (NASDAQ: AUTL ) AxoGen, Inc Common Stock (NASDAQ: AXGN ) Axovant Gene Therapies Ltd (NASDAQ: AXGT ) Bausch Health Companies Inc (NYSE: BHC ) Bellicum Pharmaceuticals Inc (NASDAQ: BLCM ) BENITEC BIOPHAR/S ADR (NASDAQ: BNTC ) BioLife Solutions Inc (NASDAQ: BLFS ) bluebird bio Inc (NASDAQ: BLUE ) Black Diamond Therapeutics Inc (NASDAQ: BDTX ) Capricor Therapeutics Inc (NASDAQ: CAPR ) Celcuity Inc (NASDAQ: CELC ) Cerecor Inc (NASDAQ: CERC ) Chembio Diagnostics Inc (NASDAQ: CEMI ) Eiger Biopharmaceuticals Inc (NASDAQ: EIGR ) Enochian Biosciences Inc (NASDAQ: ENOB ) Entasis Therapeutics Holdings Inc (NASDAQ: ETTX ) Eton Pharmaceuticals Inc (NASDAQ: ETON ) Evolus Inc (NASDAQ: EOLS ) Exicure Inc (NASDAQ: XCUR ) Eyepoint Pharmaceuticals Inc (NASDAQ: EYPT ) Five Prime Therapeutics Inc (NASDAQ: FPRX ) Gossamer Bio Inc (NASDAQ: GOSS ) Gritstone Oncology Inc (NASDAQ: GRTS ) GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH ) Heron Therapeutics Inc (NASDAQ: HRTX ) Incyte Corporation (NASDAQ: INCY ) INmune Bio Inc (NASDAQ: INMB ) Integra Lifesciences Holdings Corp (NASDAQ: IART ) Invivo Therapeutics Holdings Corp (NASDAQ: NVIV ) Jaguar Health Inc (NASDAQ: JAGX ) Jazz Pharmaceuticals PLC (NASDAQ: JAZZ ) Kura Oncology Inc (NASDAQ: KURA ) Lantheus Holdings Inc (NASDAQ: LNTH ) TapImmune Inc.
   The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap 600 Index  2020/03/10 13:19:55 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 9.) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Enzo Biochem, Inc. (NYSE: ENZ ) Centogene NV (NASDAQ: CNTG ) Inovio Pharmaceuticals Inc (NASDAQ: INO ) Spherix Inc (NASDAQ: SPEX ) ( added to Friday's advance on clinching an option agreement for coronavirus treatment) Down In The Dumps (Biotech stocks that hit 52-week lows March 9.) ABIOMED, Inc. (NASDAQ: ABMD ) Acasti Pharma Inc (NASDAQ: ACST ) Achieve Life Sciences Inc (NASDAQ: ACHV ) Acorda Therapeutics Inc (NASDAQ: ACOR ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) ADMA Biologics Inc (NASDAQ: ADMA ) Aeglea Bio Therapeutics Inc (NASDAQ: AGLE ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Affimed NV (NASDAQ: AFMD ) Akers Biosciences Inc (NASDAQ: AKER ) Akorn, Inc. (NASDAQ: AKRX ) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) Alexion Pharmaceuticals, Inc.
   Heron Therapeutics (HRTX) May Report Negative Earnings: Know the Trend Ahead of Q4 Release  2020/02/21 18:34:46 Zacks Investment Research
Heron Therapeutics (HRTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   Global Postoperative Pain: Market Forecast to 2028 - Featuring Heron Therapeutics, Pfizer, Cara Therapeutics & Neumentum Pharmaceuticals Among Others - ResearchAndMarkets.com  2020/02/12 15:10:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Postoperative Pain - Market Insights, Epidemiology and Market Forecast - 2028" report has been added to ResearchAndMarkets.com's offering. This report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of Postoperative Pain in the United States, EU5 (Germany, Spain, Italy, France and the United Kingdom), and Japan. The report provides the current treatment practices, emerging drugs, market share
   Introducing Heron Therapeutics (NASDAQ:HRTX), The Stock That Zoomed 186% In The Last Five Years  2020/01/27 16:01:21 Yahoo Finance
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But when you pick a…

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 ヘロン・セラピュ―ティクス HRTX Heron Therapeutics Inc. )

 twitter  (公式ツイッターやCEOツイッターなど)